Cargando…
Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis
BACKGROUND: Acyl-CoA dehydrogenase long chain (ACADL) was revealed to have a correlation with malignant progression of cancer. However, whether ACADL plays a role in clinical therapy remains unclear. The clinicopathological role of ACADL in esophageal squamous cell carcinoma (ESCC) will be discussed...
Autores principales: | Yu, Dong-Lin, Li, Hong-Wei, Wang, Yang, Li, Cun-Qi, You, Dong, Jiang, Lei, Song, Yi-Peng, Li, Xing-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217208/ https://www.ncbi.nlm.nih.gov/pubmed/30464513 http://dx.doi.org/10.2147/OTT.S171963 |
Ejemplares similares
-
Cardiac Hypertrophy in Mice with Long-Chain Acyl-CoA Dehydrogenase (LCAD) or Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
por: Cox, Keith B., et al.
Publicado: (2009) -
Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency
por: van Maldegem, Bianca T., et al.
Publicado: (2010) -
Effects of short‐chain acyl‐CoA dehydrogenase on cardiomyocyte apoptosis
por: Zeng, Zhenhua, et al.
Publicado: (2016) -
Medium‐chain Acyl‐COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment
por: Mason, Emily, et al.
Publicado: (2022) -
First case report of short-chain acyl-CoA dehydrogenase deficiency in China
por: Jiang, MinYan, et al.
Publicado: (2013)